Diabetes Vaccine Market
Diabetes is one of most prevalent chronic diseases worldwide. According to WHO (World Health Organization), diabetes was one of top three leading causes of mortality in 2012. The diabetes vaccine currently under development has significant potential in younger age group (Below 20 years age), who are characterized by a stronger autoimmune response to combat infection from specific viruses.
Diabetes is one of most prevalent chronic diseases worldwide. According to WHO (World Health Organization), diabetes was one of top three leading causes of mortality in 2012. The diabetes vaccine currently under development has significant potential in younger age group (Below 20 years age), who are characterized by a stronger autoimmune response to combat infection from specific viruses.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Diabetes</strong> <strong>Vaccine</strong> <strong>Market</strong> -<br />
INDUSTRYINSIGHTS, TRENDS, OUTLOOK, AND<br />
OPPORTUNITY ANALYSIS, 2016–2024<br />
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION<br />
<strong>Diabetes</strong> <strong>Vaccine</strong> <strong>Market</strong> : Overview<br />
<strong>Diabetes</strong> is one of most prevalent chronic diseases worldwide. According to WHO<br />
(World Health Organization), diabetes was one of top three leading causes of<br />
mortality in 2012. The diabetes vaccine currently under development has significant<br />
potential in younger age group (Below 20 years age), who are characterized by a<br />
stronger autoimmune response to combat infection from specific viruses. <strong>Diabetes</strong><br />
vaccine is being developed to strengthen the body’s response against enterovirus<br />
called coxsackievirus B1, wherein it senses enterovirus and produces immune<br />
response to destroy it. It destroys the insulin producing beta cell in pancreas, which<br />
is linked with type 1 diabetes. Though currently there is no approved diabetes<br />
vaccine available, however, key players are focusing on research to develop such<br />
vaccines by targeting various mechanisms that triggers the autoimmune response.<br />
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION<br />
<strong>Diabetes</strong> <strong>Vaccine</strong> <strong>Market</strong> : Taxonomy<br />
On the basis of age group, the global diabetes vaccine market is segmented into:<br />
●<br />
Up to 20 years of age<br />
●<br />
Above 20 years of age<br />
On the basis of end user, the global diabetes vaccine market is segmented into:<br />
●<br />
●<br />
●<br />
Hospitals<br />
Clinics<br />
Others<br />
Request Report Sample @<br />
https://www.coherentmarketinsights.com/insight/request-sample/1367<br />
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION<br />
<strong>Diabetes</strong> <strong>Vaccine</strong> <strong>Market</strong> : Key Players<br />
●<br />
●<br />
Imcys— a Belgium-based biotech company— announced plans to commence its<br />
clinical trial in 2018 for new diabetes vaccine to treat type 1 diabetes. It uses<br />
modified peptides called imotopes, which spurs specific type of immune cell to<br />
kill immune cells that work on the insulin producing beta cells.<br />
Moreover, in 2017, Massachusetts General Hospital Immunobiology Laboratory<br />
presented findings of clinical trial at 75th Scientific Sessions of the American<br />
<strong>Diabetes</strong> Association, related to use of BCG vaccine to treat autoimmune<br />
response in type 1 diabetes. BCG vaccine could induce a permanent gene<br />
expression that restores regulatory T cells, thereby preventing the immune system<br />
attack, which is observed in type 1 diabetes. It is currently under phase two<br />
clinical trial.<br />
Get More Details About This Report@<br />
https://www.coherentmarketinsights.com/ongoing-insight/diabetes-vaccinemarket-1367<br />
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS<br />
ABOUT US<br />
Coherent <strong>Market</strong> Insights is a global market intelligence and consulting<br />
organization focused on assisting its plethora of clients achieve transformational<br />
growth by helping them make critical business decisions. We are headquartered in<br />
India, with an office at the global financial capital in the U.S. Our client base<br />
includes players from across all business verticals in over 150 countries worldwide.<br />
We are uniquely positioned to help businesses around the globe deliver practical<br />
and lasting results through various recommendations about operational<br />
improvements, technologies, emerging market trends and new working methods.<br />
We offer both customized and syndicated market research reports that help our<br />
clients create visionary growth plans to provide traction to their business. We<br />
meticulously study emerging trends across various industries at both the global and<br />
regional levels to identify new opportunities for our clientele.<br />
SERVICES<br />
INDUSTRY ANALYSIS<br />
MARKET INTELLIGENCE<br />
SERVICES<br />
CUSTOMIZED<br />
RESEARCH<br />
CONSULT STUDIES<br />
SYNDICATED RESEARCH<br />
COUNTRY SPECIFIC<br />
STUDIES<br />
© Coherent market Insights. All Rights Reserved
ABOUT CMI<br />
SECTOR<br />
COVERAGE<br />
BIOTECHNOLOGY<br />
CLINICAL<br />
DIAGNOSTIC<br />
HEALTHCARE IT<br />
MEDICAL DEVICES<br />
MEDICAL<br />
IMAGING<br />
PHARMACEUTICAL<br />
OUR CLIENTS<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
Global Leading Equipment and System Manufacturers<br />
Component Providers and System Integrators<br />
Distributors, Retailors and Value Added Resellers<br />
Healthcare IT Solutions Developers<br />
<strong>Market</strong>ing Consultancies and the Advertising Industry<br />
Private and Government organization<br />
Outsourcing Companies<br />
Universities and Business Schools.<br />
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS<br />
KEY STATS<br />
RESEARCH SOLUTIONS<br />
FEASIBILITY<br />
STUDIES<br />
GLOBAL<br />
REPORTS<br />
100+<br />
Insights Published Per<br />
Year<br />
150+<br />
Consulting Projects Till Date<br />
125+<br />
Clients Worldwide Per Year<br />
CONSULT<br />
PROJECTS<br />
SURVEY<br />
RESEAR<br />
CH<br />
EXCEL<br />
FORECAST<br />
DATABASE<br />
COUNTRY<br />
ANALYSIS<br />
COMPETITIVE<br />
ASSESSMENT<br />
110+<br />
TECHNOLOGY<br />
SNIPPETS<br />
Analysts and Contract Consultants<br />
Coherent <strong>Market</strong> Insights excels at offering unmatched actionable market intelligence across various industry verticals, including<br />
chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in<br />
the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various<br />
industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely<br />
designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed<br />
markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein.<br />
© Coherent market Insights. All Rights Reserved
THANK YOU<br />
To know more about us, visit our website:<br />
www.coherentmarketinsights.com<br />
For sales queries or new topics email us on:<br />
sales@coherentmarketinsights.com<br />
For other queries contact:<br />
Mr. Shah<br />
(Manager - Business Development)<br />
Coherent <strong>Market</strong> Insights<br />
sales@coherentmarketinsights.com<br />
+1-206-701-6702<br />
© Coherent market Insights. All Rights Reserved
Change language